Thomas J. Matthews

Research interests

Publications

• AVONET: morphological, ecological and geographical data for all birds

  Ecology Letters · 2022 · https://doi.org/10.1111/ele.13898

• Island biogeography: Taking the long view of nature’s laboratories

  Science · 2017 · https://doi.org/10.1126/science.aam8326

• A roadmap for island biology: 50 fundamental questions after 50 years of The Theory of Island Biogeography

  Journal of Biogeography · 2017 · https://doi.org/10.1111/jbi.12986

• On the form of species–area relationships in habitat islands and true islands

  Global Ecology and Biogeography · 2015 · https://doi.org/10.1111/geb.12269

• REVIEW: On the species abundance distribution in applied ecology and biodiversity management

  Journal of Applied Ecology · 2014 · https://doi.org/10.1111/1365-2664.12380

• Habitat fragmentation and the species–area relationship: a focus on total species richness obscures the impact of habitat loss on habitat specialists

  Diversity and Distributions · 2014 · https://doi.org/10.1111/ddi.12227

• Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus

  Proceedings of the National Academy of Sciences · 2007 · https://doi.org/10.1073/pnas.0701478104

• Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

  Nature Medicine · 1998 · https://doi.org/10.1038/3293

• Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides

  Journal of Virology · 1998 · https://doi.org/10.1128/jvi.72.2.986-993.1998

• A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion

  Journal of Virology · 1995 · https://doi.org/10.1128/jvi.69.6.3771-3777.1995

• Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

  Proceedings of the National Academy of Sciences · 1994 · https://doi.org/10.1073/pnas.91.21.9770

• Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex.

  Proceedings of the National Academy of Sciences · 1994 · https://doi.org/10.1073/pnas.91.26.12676

• A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion

  AIDS Research and Human Retroviruses · 1993 · https://doi.org/10.1089/aid.1993.9.1051

• A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

  Proceedings of the National Academy of Sciences · 1992 · https://doi.org/10.1073/pnas.89.21.10537

• Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

  Nature · 1990 · https://doi.org/10.1038/343090a0

• Broadly Neutralizing Antibodies Elicited by the Hypervariable Neutralizing Determinant of HIV-1

  Science · 1990 · https://doi.org/10.1126/science.1703322

• Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant

  Science · 1990 · https://doi.org/10.1126/science.2392685

• HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.

  The Journal of Immunology · 1989 · https://doi.org/10.4049/jimmunol.142.9.3091

• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.

  Proceedings of the National Academy of Sciences · 1988 · https://doi.org/10.1073/pnas.85.6.1932

• Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4

  Journal of Virology · 1988 · https://doi.org/10.1128/jvi.62.11.4195-4200.1988

• Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.

  Proceedings of the National Academy of Sciences · 1987 · https://doi.org/10.1073/pnas.84.15.5424

• Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

  Proceedings of the National Academy of Sciences · 1986 · https://doi.org/10.1073/pnas.83.24.9709

• Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.

  Proceedings of the National Academy of Sciences · 1986 · https://doi.org/10.1073/pnas.83.18.7023

• HTLV-III/LAV-Neutralizing Antibodies to an E. coli -Produced Fragment of the Virus Envelope

  Science · 1986 · https://doi.org/10.1126/science.2431482

• Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

  PubMed · 1983

Current projects

No projects listed.